+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032- Product Image
Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032- Product Image
New

Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460252
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Nucleic acid amplification testing is fundamentally reshaping molecular diagnostics, providing the precision and speed needed for contemporary clinical and research environments. As demand rises worldwide, senior decision-makers require up-to-date intelligence to guide technology investment, procurement, and overarching diagnostic strategies.

Market Snapshot: Nucleic Acid Amplification Testing Market Size and Growth

The Nucleic Acid Amplification Testing Market is experiencing significant momentum, expanding from USD 4.00 billion in 2025 to USD 4.54 billion in 2026. With a projected CAGR of 13.20%, the market is on track to reach USD 9.54 billion by 2032. This trajectory highlights the expanding role of rapid, high-sensitivity molecular diagnostics not only in healthcare but also in fields like public health and life sciences research. Market growth is influenced by increasing clinical adoption, research needs for advanced genetic analysis, and the requirement for scalable solutions across diverse care settings.

Nucleic Acid Amplification Testing Market: Scope & Segmentation

This report delivers an actionable segmentation of the global NAAT landscape, enabling precise assessment of growth channels and investment areas. Segments covered include:

  • Technology Types: Isothermal amplification—including helicase dependent, loop mediated, nucleic acid sequence based, strand displacement, and transcription mediated approaches—alongside traditional and advanced polymerase chain reaction modalities such as digital and real-time PCR. These platforms deliver tailored sensitivity, workflow efficiency, and suitability for centralized labs or point-of-care applications.
  • Product Categories: Instruments in benchtop and portable formats; reagents and kits incorporating buffers, enzymes, master mixes, primers, and probes; as well as supporting software and services for data analytics, equipment maintenance, and staff training.
  • End Users: Diagnostic laboratories, hospitals, point-of-care settings, and research institutions, each presenting distinct operational and compliance requirements. These end users influence purchasing decisions across the diagnostic workflow.
  • Application Domains: Infectious disease diagnostics, oncology, companion diagnostics, and genetic testing—including prenatal, carrier, and rare disease screening—each requiring targeted validation protocols and addressing unique patient and population health needs.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting differences in regulatory environments, infrastructure maturity, and supply chain complexity.

Key Takeaways for Senior Decision-Makers

  • Isothermal amplification and digital PCR technology advancements streamline assay speed and workflow, making them highly effective for both core laboratories and point-of-care integration.
  • Sample-to-answer systems and advanced data analytics are reducing manual requirements and enabling quicker, more informed laboratory decision-making with minimal operator input.
  • Organizations are reevaluating supplier contracts and favoring diversified sourcing strategies to address volatility in supply chains, particularly in the context of changing international trade dynamics.
  • Collaborative partnerships among instrument manufacturers, reagent firms, and software providers offer complete diagnostic solutions, enhancing end-customer satisfaction through ongoing service and support.
  • Regional strategies that balance global technology standards with compliance, payer requirements, and local infrastructure ensure competitive positioning and access.
  • Investment in structured training, quality assurance, and platform interoperability supports reliable diagnostic outcomes and provides differentiation in an evolving marketplace.

Tariff Impact: Adjusting Supply Chains and Procurement in Diagnostics

Recent adjustments to U.S. tariffs have intensified focus on the resilience of NAAT supply chains. Increased import duties on key components such as enzymes and instrumentation have led manufacturers to pursue local assembly, nearshoring, and strategic inventory management. Procurement teams now systematically review supplier relationships, seeking risk mitigation and continuity by incorporating regional alternatives. This dynamic boosts the role of suppliers able to insulate clients from tariffs and logistical volatility, shaping sourcing policies in both short and long-term procurement cycles.

Nucleic Acid Amplification Testing Market: Methodology & Data Sources

This report relies on a mixed-method research approach, integrating structured interviews with laboratory executives, equipment manufacturers, and compliance experts. Supplementary validation is provided through analysis of peer-reviewed publications and direct company disclosures, with a final review by domain specialists to ensure broad applicability and accuracy across global healthcare markets.

Why This Report Matters: Strategic Value for Decision-Makers

  • Build effective procurement, partnership, and product planning strategies with clear insight into technology evolution, competitive structure, and decision-driver dynamics.
  • Identify compliance pathways, commercialization approaches, and supply chain options tailored for varied regional and clinical settings.
  • Support targeted investment and resource allocation with rigorously validated, stakeholder-driven intelligence and up-to-date technical documentation.

Conclusion

Rapid innovation, the development of robust supply chains, and integrated service delivery models are fundamentally redefining the NAAT landscape. Aligning strategy with these market drivers positions senior decision-makers for scalable, successful diagnostic implementations amid evolving regulatory and operational requirements.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Nucleic Acid Amplification Testing Market, by Technology
8.1. Isothermal Amplification
8.1.1. Helicase Dependent Amplification
8.1.2. Loop Mediated Amplification
8.1.3. Nucleic Acid Sequence Based Amplification
8.1.4. Strand Displacement Amplification
8.1.5. Transcription Mediated Amplification
8.2. Polymerase Chain Reaction
8.2.1. Digital Polymerase Chain Reaction
8.2.2. Real Time Polymerase Chain Reaction
9. Nucleic Acid Amplification Testing Market, by Product Type
9.1. Instruments
9.1.1. Benchtop Instruments
9.1.2. Portable Instruments
9.2. Reagents & Kits
9.2.1. Buffers
9.2.2. Enzymes
9.2.3. Master Mixes
9.2.4. Primers & Probes
9.3. Software & Services
9.3.1. Data Analysis Software
9.3.2. Maintenance & Support
9.3.3. Training & Consulting Services
10. Nucleic Acid Amplification Testing Market, by End User
10.1. Diagnostic Laboratories
10.2. Hospitals
10.3. Point Of Care Testing
10.4. Research Institutes
11. Nucleic Acid Amplification Testing Market, by Application
11.1. Companion Diagnostics
11.2. Genetic Testing
11.2.1. Carrier Screening
11.2.2. Prenatal Genetic Testing
11.2.3. Rare Disease Diagnostics
11.3. Infectious Disease
11.3.1. Bacterial Infectious Disease
11.3.2. Parasitic Infectious Disease
11.3.3. Viral Infectious Disease
11.4. Oncology
11.4.1. Biomarker Testing
11.4.2. Minimal Residual Disease Detection
11.4.3. Mutation Analysis
12. Nucleic Acid Amplification Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Nucleic Acid Amplification Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Nucleic Acid Amplification Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Nucleic Acid Amplification Testing Market
16. China Nucleic Acid Amplification Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Becton, Dickinson and Company
17.7. BGI Genomics Co. Ltd.
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. Bruker Corporation
17.11. Danaher Corporation
17.12. Diasorin S.p.A.
17.13. F. Hoffmann-La Roche AG
17.14. Grifols, S.A.
17.15. Hologic, Inc.
17.16. Molbio Diagnostics Pvt. Ltd.
17.17. Mylab Discovery Solutions
17.18. Pfizer Inc
17.19. QuidelOrtho Corporation
17.20. Randox Laboratories Ltd
17.21. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 188. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 189. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 192. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 207. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 210. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 211. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 213. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 214. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 215. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 218. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 219. AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 237. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 238. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 239. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 240. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 241. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 242. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 245. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 246. ASEAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 247. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 250. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 251. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 253. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 254. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 255. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 258. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 259. GCC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 273. BRICS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. BRICS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. BRICS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 276. BRICS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY P

Companies Mentioned

The key companies profiled in this Nucleic Acid Amplification Testing market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Diasorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Grifols, S.A.
  • Hologic, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Mylab Discovery Solutions
  • Pfizer Inc
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.54 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.54 Billion
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Isothermal Nucleic Acid Amplification Technology Market - Global Forecast 2026-2032 - Product Image

Isothermal Nucleic Acid Amplification Technology Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Nucleic Acid Amplification Testing Market Report 2025 - Product Image

Nucleic Acid Amplification Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Nucleic Acid Amplification Testing Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034) - Product Image

Nucleic Acid Amplification Testing Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Nucleic Acid Amplification Analyzer Market - Global Forecast 2025-2030 - Product Image

Nucleic Acid Amplification Analyzer Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Infectious Disease Molecular Diagnostics Market Report and Forecast 2025-2034 - Product Image

Infectious Disease Molecular Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.